219 related articles for article (PubMed ID: 31358530)
1. Targeting Mechanoresponsive Proteins in Pancreatic Cancer: 4-Hydroxyacetophenone Blocks Dissemination and Invasion by Activating MYH14.
Surcel A; Schiffhauer ES; Thomas DG; Zhu Q; DiNapoli KT; Herbig M; Otto O; West-Foyle H; Jacobi A; Kräter M; Plak K; Guck J; Jaffee EM; Iglesias PA; Anders RA; Robinson DN
Cancer Res; 2019 Sep; 79(18):4665-4678. PubMed ID: 31358530
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological activation of myosin II paralogs to correct cell mechanics defects.
Surcel A; Ng WP; West-Foyle H; Zhu Q; Ren Y; Avery LB; Krenc AK; Meyers DJ; Rock RS; Anders RA; Freel Meyers CL; Robinson DN
Proc Natl Acad Sci U S A; 2015 Feb; 112(5):1428-33. PubMed ID: 25605895
[TBL] [Abstract][Full Text] [Related]
3. Mechanoaccumulative Elements of the Mammalian Actin Cytoskeleton.
Schiffhauer ES; Luo T; Mohan K; Srivastava V; Qian X; Griffis ER; Iglesias PA; Robinson DN
Curr Biol; 2016 Jun; 26(11):1473-1479. PubMed ID: 27185555
[TBL] [Abstract][Full Text] [Related]
4. α-actinin-4 is essential for maintaining the spreading, motility and contractility of fibroblasts.
Shao H; Wang JH; Pollak MR; Wells A
PLoS One; 2010 Nov; 5(11):e13921. PubMed ID: 21085685
[TBL] [Abstract][Full Text] [Related]
5. The mechanobiome: a goldmine for cancer therapeutics.
Parajón E; Surcel A; Robinson DN
Am J Physiol Cell Physiol; 2021 Mar; 320(3):C306-C323. PubMed ID: 33175572
[TBL] [Abstract][Full Text] [Related]
6. 4-Hydroxyacetophenone modulates the actomyosin cytoskeleton to reduce metastasis.
Bryan DS; Stack M; Krysztofiak K; Cichoń U; Thomas DG; Surcel A; Schiffhauer ES; Beckett MA; Khodarev NN; Xue L; Poli EC; Pearson AT; Posner MC; Robinson DN; Rock RS; Weichselbaum RR
Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22423-22429. PubMed ID: 32848073
[TBL] [Abstract][Full Text] [Related]
7. α-Actinin-4 drives invasiveness by regulating myosin IIB expression and myosin IIA localization.
Barai A; Mukherjee A; Das A; Saxena N; Sen S
J Cell Sci; 2021 Dec; 134(23):. PubMed ID: 34730180
[TBL] [Abstract][Full Text] [Related]
8. Characterization of three full-length human nonmuscle myosin II paralogs.
Billington N; Wang A; Mao J; Adelstein RS; Sellers JR
J Biol Chem; 2013 Nov; 288(46):33398-410. PubMed ID: 24072716
[TBL] [Abstract][Full Text] [Related]
9. Mosaic loss of non-muscle myosin IIA and IIB is sufficient to induce mammary epithelial proliferation.
Nguyen-Ngoc KV; Silvestri VL; Georgess D; Fairchild AN; Ewald AJ
J Cell Sci; 2017 Oct; 130(19):3213-3221. PubMed ID: 28821574
[TBL] [Abstract][Full Text] [Related]
10. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice.
Huang M; Tang SN; Upadhyay G; Marsh JL; Jackman CP; Srivastava RK; Shankar S
Cancer Lett; 2014 Oct; 353(1):32-40. PubMed ID: 25050737
[TBL] [Abstract][Full Text] [Related]
11. LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.
Melisi D; Ishiyama S; Sclabas GM; Fleming JB; Xia Q; Tortora G; Abbruzzese JL; Chiao PJ
Mol Cancer Ther; 2008 Apr; 7(4):829-40. PubMed ID: 18413796
[TBL] [Abstract][Full Text] [Related]
12. Aberrant splicing and expression of the non muscle myosin heavy-chain gene MYH14 in DM1 muscle tissues.
Rinaldi F; Terracciano C; Pisani V; Massa R; Loro E; Vergani L; Di Girolamo S; Angelini C; Gourdon G; Novelli G; Botta A
Neurobiol Dis; 2012 Jan; 45(1):264-71. PubMed ID: 21872659
[TBL] [Abstract][Full Text] [Related]
13. Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer.
Kizaka-Kondoh S; Itasaka S; Zeng L; Tanaka S; Zhao T; Takahashi Y; Shibuya K; Hirota K; Semenza GL; Hiraoka M
Clin Cancer Res; 2009 May; 15(10):3433-41. PubMed ID: 19417024
[TBL] [Abstract][Full Text] [Related]
14. Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis.
Pandey P; Rachagani S; Das S; Seshacharyulu P; Sheinin Y; Naslavsky N; Pan Z; Smith BL; Peters HL; Radhakrishnan P; McKenna NR; Giridharan SS; Haridas D; Kaur S; Hollingsworth MA; MacDonald RG; Meza JL; Caplan S; Batra SK; Solheim JC
Oncotarget; 2015 Feb; 6(4):2064-75. PubMed ID: 25576918
[TBL] [Abstract][Full Text] [Related]
15. Dynamin 2 interacts with α-actinin 4 to drive tumor cell invasion.
Burton KM; Cao H; Chen J; Qiang L; Krueger EW; Johnson KM; Bamlet WR; Zhang L; McNiven MA; Razidlo GL
Mol Biol Cell; 2020 Mar; 31(6):439-451. PubMed ID: 31967944
[TBL] [Abstract][Full Text] [Related]
16. Mammalian nonmuscle myosin II comes in three flavors.
Shutova MS; Svitkina TM
Biochem Biophys Res Commun; 2018 Nov; 506(2):394-402. PubMed ID: 29550471
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK/STAT3 signaling pathway by targeting SOCS5.
Hu H; Zhang Q; Chen W; Wu T; Liu S; Li X; Luo B; Zhang T; Yan G; Lu H; Lu Z
Carcinogenesis; 2020 Jun; 41(4):502-514. PubMed ID: 31233116
[TBL] [Abstract][Full Text] [Related]
18. Multiple myosin motors interact with sodium/potassium-ATPase alpha 1 subunits.
Dash B; Dib-Hajj SD; Waxman SG
Mol Brain; 2018 Aug; 11(1):45. PubMed ID: 30086768
[TBL] [Abstract][Full Text] [Related]
19. TFPI-2 suppresses breast cancer cell proliferation and invasion through regulation of ERK signaling and interaction with actinin-4 and myosin-9.
Wang G; Huang W; Li W; Chen S; Chen W; Zhou Y; Peng P; Gu W
Sci Rep; 2018 Sep; 8(1):14402. PubMed ID: 30258071
[TBL] [Abstract][Full Text] [Related]
20. Two novel/ancient myosins in mammalian skeletal muscles: MYH14/7b and MYH15 are expressed in extraocular muscles and muscle spindles.
Rossi AC; Mammucari C; Argentini C; Reggiani C; Schiaffino S
J Physiol; 2010 Jan; 588(Pt 2):353-64. PubMed ID: 19948655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
